The causal relationship between IDH mutation and glioma pathogenesis is unclear, although it is speculated that IDH mutations result in reduced alpha-ketoglutarate function, with downstream effects on both epigenetic cellular metabolism alterations [7]. The gene discussed is IDH2; the disease is central nervous system cancer.